Metro Healthcare BhdXKLS:0329 59 FCF Yield % is 3.83 as of Jul. 05, 2026, which is 46% above its 10-year median of 2.63. GuruFocus rates XKLS:0329 with a GF Score™ of 59/100 and a GF Value™ of RM0.32 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Metro Healthcare Bhd ranks better than 60.5% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Metro Healthcare Bhd's FCF Yield % or its related term are showing as below:
XKLS:0329'
s FCF Yield % Range Over the Past 10 Years
Min: -0.45 Med: 2.63 Max: 4.12
Current: 3.83
During the past 11 years, the highest FCF Yield % of Metro Healthcare Bhd was 4.12%. The lowest was -0.45%. And the median was 2.63%.
XKLS:0329's FCF Yield % is ranked better than 60.5% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.83
vs XKLS:0329: 3.83
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Metro Healthcare Bhd FCF Yield % Related Terms
Metro Healthcare Bhd FCF Yield % Historical Data
* Premium members only.
The historical data trend for Metro Healthcare Bhd's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0329 vs HCA, THC, DVA: FCF Yield % Comparison
For the Medical Care Facilities subindustry, Metro Healthcare Bhd's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metro Healthcare Bhd FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Metro Healthcare Bhd's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Metro Healthcare Bhd's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metro Healthcare Bhd (XKLS:0329) has a FCF Yield % of 3.83 as of Jul. 05, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Metro Healthcare Bhd and its competitors. This is 46% above median its historical median of 2.63. According to the industry distribution chart, Metro Healthcare Bhd ranks #269 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 39.5%.
Is Metro Healthcare Bhd's FCF Yield % too high?
Metro Healthcare Bhd's current FCF Yield % of 3.83 is 46% above median its 10-year median of 2.63. The Healthcare Providers & Services industry median FCF Yield % is 1.83. Metro Healthcare Bhd's value of 3.83 is 109.3% above this industry median. Based on the distribution chart, Metro Healthcare Bhd ranks #269 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Metro Healthcare Bhd has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's FCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Metro Healthcare Bhd ranks #269 out of 681 companies for FCF Yield %. This puts Metro Healthcare Bhd in the upper half of its industry. The industry median FCF Yield % is 1.83. Metro Healthcare Bhd's value of 3.83 is 109.3% above this benchmark. While the company's 10-year median is 2.63 vs. the industry median of 1.83, Metro Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.83, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metro Healthcare Bhd's current FCF Yield % of 3.83 is 109.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Metro Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metro Healthcare Bhd's current FCF Yield % is 3.83, which is 46% above median its own 10-year median of 2.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.32, compared to a current price of RM0.22 — trading 32.8% below its estimated fair value. The current FCF Yield % is 3.83, which is 46% above median its 10-year median of 2.63 and 109.3% above the Healthcare Providers & Services industry median of 1.83. Metro Healthcare Bhd's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current FCF Yield % is 3.83 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?
Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued.
The current stock price of RM0.22 is trading 32.8% below its estimated GF Value™ of RM0.32.
GuruFocus considers Metro Healthcare Bhd to be Possible Value Trap.
Key valuation signals for XKLS:0329:
FCF Yield %: 3.83 (46% above median its 10-year median of 2.63)
GF Value™: RM0.32 vs. price of RM0.22 (32.8% below fair value)
Industry Position: 109.3% above the Healthcare Providers & Services median (#269 of 681)
No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
59GF Score
Get the complete analysis for XKLS:0329
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0329 has been successfully added to your 
